David J. Rawlings

1.3k citations
11 papers · 1.0k indexed · h-index 6
Topics
T-cell and B-cell Immunology (5 papers)Immune Cell Function and Interaction (5 papers)CAR-T cell therapy research (3 papers)
Partner nations
United States

In The Last Decade

David J. Rawlings

10 papers receiving 994 citations

Peers

David J. Rawlings
Comparison fields: 5 of 66
  • Immunology 669
  • Molecular Biology 351
  • Cancer Research 291
  • Genetics 230
  • Oncology 198
Replace Archito T. Tamayo with:
Archito T. Tamayo United States
José La Rose Canada
Javier Redondo-Muñóz Spain
Lan V. Pham United States
Sébastien Letard France
Yuzuru Kanakura Japan
Fabien Garçon United Kingdom
Thomas Wossning Germany
Trevor Blake United States
W Zhang United States
David J. Rawlings relative to Archito T. Tamayo United States Archito T. Tamayo's profile →
Citations per field
00.5×1.7×
Archito T. Tamayo · 1×
Citations per year

Countries citing papers authored by David J. Rawlings

Since Specialization
Citations

This map shows the geographic impact of David J. Rawlings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Rawlings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Rawlings more than expected).

Fields of papers citing papers by David J. Rawlings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Rawlings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Rawlings. The network helps show where David J. Rawlings may publish in the future.

Co-authorship network of co-authors of David J. Rawlings

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Rawlings. A scholar is included among the top collaborators of David J. Rawlings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Rawlings. David J. Rawlings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 5
3 2
4 2
5 2
6 13
7 90
8 276
9 270
10 83
11 262

About David J. Rawlings

David J. Rawlings is a scholar working on Immunology, Genetics and Oncology, having authored 11 papers that have together received 1.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Immunology (669 citations), Genetics (230 citations) and Cancer Research (291 citations). David J. Rawlings has collaborated with scholars based in United States. Frequent co-authors include Karen Sommer, Beichu Guo, Ashok D. Bandaranayake, Miguel E. Moreno‐García, Joel L. Pomerantz, Yulia Ovechkina, Andrew M. Scharenberg, Christina Tam, Matthew I. Wahl and Daniel Afar. Their work appears in journals such as Immunity, Nature Biotechnology and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026